Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.42 EUR | -1.63% |
|
+1.07% | +4.24% |
Jul. 03 | AKZONOBEL : Debt repayment stabilises the rating | ![]() |
Jul. 03 | AKZO NOBEL NV : Jefferies reaffirms its Neutral rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.67 | 5.03 | 3.17 | 4.53 | 4.1 | |||||
Return on Total Capital | 6.93 | 7.55 | 4.63 | 6.47 | 5.81 | |||||
Return On Equity % | 10.83 | 14.83 | 7.62 | 10.73 | 12.65 | |||||
Return on Common Equity | 10.53 | 14.73 | 7.42 | 10.33 | 12.19 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 44.37 | 40.21 | 36.17 | 39.69 | 40.49 | |||||
SG&A Margin | 30.07 | 26.71 | 27.1 | 27.77 | 28.86 | |||||
EBITDA Margin % | 14.53 | 14.04 | 9.18 | 12.37 | 11.34 | |||||
EBITA Margin % | 12.2 | 12.09 | 7.5 | 10.7 | 9.54 | |||||
EBIT Margin % | 11.45 | 11.36 | 6.69 | 9.96 | 8.81 | |||||
Income From Continuing Operations Margin % | 7.95 | 8.96 | 3.58 | 4.57 | 5.53 | |||||
Net Income Margin % | 7.39 | 8.65 | 3.25 | 4.14 | 5.06 | |||||
Net Avail. For Common Margin % | 7.47 | 8.58 | 3.34 | 4.19 | 5.06 | |||||
Normalized Net Income Margin | 6.25 | 6.37 | 3.23 | 4.48 | 4.34 | |||||
Levered Free Cash Flow Margin | 11.12 | 1.3 | 0.46 | 8.71 | 1.69 | |||||
Unlevered Free Cash Flow Margin | 11.67 | 1.78 | 1.07 | 9.84 | 2.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.65 | 0.71 | 0.76 | 0.73 | 0.74 | |||||
Fixed Assets Turnover | 4.24 | 4.74 | 4.97 | 4.68 | 4.52 | |||||
Receivables Turnover (Average Receivables) | 4.79 | 5.14 | 5.3 | 4.95 | 4.95 | |||||
Inventory Turnover (Average Inventory) | 4.13 | 4.08 | 3.96 | 3.68 | 3.78 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.64 | 1.1 | 1.09 | 1.06 | 1.23 | |||||
Quick Ratio | 1.25 | 0.75 | 0.75 | 0.76 | 0.86 | |||||
Operating Cash Flow to Current Liabilities | 0.39 | 0.12 | 0.04 | 0.2 | 0.14 | |||||
Days Sales Outstanding (Average Receivables) | 76.44 | 71.06 | 68.92 | 73.73 | 74 | |||||
Days Outstanding Inventory (Average Inventory) | 88.63 | 89.43 | 92.08 | 99.05 | 96.75 | |||||
Average Days Payable Outstanding | 150.36 | 129.27 | 117.51 | 132.14 | 128.66 | |||||
Cash Conversion Cycle (Average Days) | 14.71 | 31.22 | 43.49 | 40.64 | 42.09 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 48.57 | 62.99 | 129.18 | 122.37 | 111.46 | |||||
Total Debt / Total Capital | 32.69 | 38.65 | 56.37 | 55.03 | 52.71 | |||||
LT Debt/Equity | 46.57 | 35.38 | 73.26 | 69.62 | 76.22 | |||||
Long-Term Debt / Total Capital | 31.35 | 21.71 | 31.97 | 31.31 | 36.05 | |||||
Total Liabilities / Total Assets | 54.85 | 59.39 | 69.15 | 68.77 | 66.2 | |||||
EBIT / Interest Expense | 12.86 | 14.72 | 6.85 | 5.5 | 4.97 | |||||
EBITDA / Interest Expense | 17.61 | 19.46 | 10.32 | 7.35 | 6.92 | |||||
(EBITDA - Capex) / Interest Expense | 14.21 | 15.57 | 7.57 | 5.87 | 5.31 | |||||
Total Debt / EBITDA | 2.16 | 2.47 | 5.37 | 3.92 | 4.08 | |||||
Net Debt / EBITDA | 0.77 | 1.62 | 3.74 | 2.67 | 2.97 | |||||
Total Debt / (EBITDA - Capex) | 2.68 | 3.08 | 7.33 | 4.91 | 5.32 | |||||
Net Debt / (EBITDA - Capex) | 0.96 | 2.03 | 5.1 | 3.34 | 3.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -8.04 | 12.39 | 13.13 | -1.64 | 0.4 | |||||
Gross Profit, 1 Yr. Growth % | -4.47 | 1.85 | 0.49 | 7.93 | 2.43 | |||||
EBITDA, 1 Yr. Growth % | 10.92 | 9.88 | -26 | 32.53 | -7.95 | |||||
EBITA, 1 Yr. Growth % | 12.06 | 12.85 | -29.85 | 40.47 | -10.51 | |||||
EBIT, 1 Yr. Growth % | 13.34 | 13.08 | -33.33 | 46.28 | -11.11 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 22.16 | 26.7 | -54.83 | 25.77 | 21.31 | |||||
Net Income, 1 Yr. Growth % | 16.88 | 31.59 | -57.54 | 25.57 | 22.62 | |||||
Normalized Net Income, 1 Yr. Growth % | 17.84 | 14.53 | -42.66 | 31.7 | -2.8 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 37.19 | 33.43 | -53.5 | 26.7 | 21.07 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.37 | 13.19 | 7.6 | 3.01 | -1.97 | |||||
Inventory, 1 Yr. Growth % | 1.76 | 42.36 | 11.7 | -10.53 | 4.37 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.22 | 8.17 | 7.37 | 1.64 | 6.27 | |||||
Total Assets, 1 Yr. Growth % | 1.49 | 5.32 | 6.22 | -1.24 | -2.12 | |||||
Tangible Book Value, 1 Yr. Growth % | -19.56 | -20.85 | -84.96 | -7.66 | 117.84 | |||||
Common Equity, 1 Yr. Growth % | -9.51 | -5.59 | -20.13 | -0.25 | 5.83 | |||||
Cash From Operations, 1 Yr. Growth % | 5.19K | -50.37 | -57.95 | 340.94 | -40.36 | |||||
Capital Expenditures, 1 Yr. Growth % | 20.56 | 11.63 | 1.39 | -2.05 | 6.99 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 128.19 | -86.88 | -60.2 | 1.78K | -80.49 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 111.05 | -82.71 | -32.16 | 806.91 | -71.42 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.63 | 1.54 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4 | 1.66 | 12.76 | 5.49 | -0.62 | |||||
Gross Profit, 2 Yr. CAGR % | -1.82 | -1.36 | 1.81 | 4.14 | 5.14 | |||||
EBITDA, 2 Yr. CAGR % | 20.45 | 9.77 | -9.83 | -0.97 | 10.45 | |||||
EBITA, 2 Yr. CAGR % | 24.37 | 11.7 | -11.03 | -0.74 | 12.12 | |||||
EBIT, 2 Yr. CAGR % | 26.04 | 12.4 | -13.17 | -1.25 | 14.03 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 22.07 | 24.41 | -24.35 | -24.63 | 23.52 | |||||
Net Income, 2 Yr. CAGR % | -69.28 | 24.02 | -25.25 | -26.98 | 24.09 | |||||
Normalized Net Income, 2 Yr. CAGR % | 35.04 | 16.17 | -18.96 | -11.57 | 13.14 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 37.57 | 35.3 | -21.23 | -23.24 | 23.85 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.53 | 4.59 | 10.11 | 5.28 | 0.49 | |||||
Inventory, 2 Yr. CAGR % | 0.87 | 20.36 | 26.1 | -0.03 | -3.37 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 5.48 | 0.72 | 7.77 | 4.46 | 3.93 | |||||
Total Assets, 2 Yr. CAGR % | -16.24 | 3.39 | 5.77 | 2.42 | -1.68 | |||||
Tangible Book Value, 2 Yr. CAGR % | -48.84 | -20.21 | -65.49 | -62.73 | 41.83 | |||||
Common Equity, 2 Yr. CAGR % | -30.32 | -7.57 | -13.16 | -10.74 | 2.74 | |||||
Cash From Operations, 2 Yr. CAGR % | 54.02 | 412.45 | -54.32 | 36.17 | 62.17 | |||||
Capital Expenditures, 2 Yr. CAGR % | 18.41 | 16.01 | 6.39 | -0.35 | 2.37 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -38.39 | -45.29 | -77.15 | 173.32 | 91.35 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -37.6 | -39.86 | -65.75 | 148.04 | 60.99 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.77 | 2.08 | 0.77 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -3.9 | 1.18 | 5.35 | 7.74 | 3.76 | |||||
Gross Profit, 3 Yr. CAGR % | -3.67 | -0.61 | -0.33 | 3.81 | 3.57 | |||||
EBITDA, 3 Yr. CAGR % | 4.24 | 16.38 | -3.75 | 2.52 | -3.36 | |||||
EBITA, 3 Yr. CAGR % | 8.37 | 19.86 | -4.35 | 3.6 | -4.11 | |||||
EBIT, 3 Yr. CAGR % | 6.1 | 20.98 | -5.56 | 3.32 | -4.65 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 9.88 | 23.59 | -11.25 | -10.38 | -11.67 | |||||
Net Income, 3 Yr. CAGR % | -8.85 | -50.11 | -13.24 | -11.14 | -13.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.57 | 27.82 | -8.19 | -3.6 | -8.73 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 19.29 | 36.18 | -5.23 | -7.71 | -10.65 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.99 | 2.45 | 5.42 | 7.69 | 2.81 | |||||
Inventory, 3 Yr. CAGR % | 1.94 | 13.15 | 17.4 | 12.47 | 1.41 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.02 | 6.37 | 2.89 | 5.69 | 5.06 | |||||
Total Assets, 3 Yr. CAGR % | -6.61 | -9.6 | 4.32 | 3.38 | 0.88 | |||||
Tangible Book Value, 3 Yr. CAGR % | -3.72 | -40.83 | -54.25 | -52.09 | -32.86 | |||||
Common Equity, 3 Yr. CAGR % | -0.68 | -22.89 | -11.96 | -9.06 | -5.53 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.89 | 5.59 | 122.69 | -2.73 | 3.41 | |||||
Capital Expenditures, 3 Yr. CAGR % | 1.06 | 16.11 | 10.91 | 3.49 | 2.04 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -16.47 | -63.21 | -50.79 | -0.67 | 13.37 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -13.92 | -59.44 | -37.4 | 2.08 | 20.7 | |||||
Dividend Per Share, 3 Yr. CAGR % | -11.49 | 2.36 | 1.38 | 0.51 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -10.51 | 0.32 | 2.45 | 2.88 | 2.92 | |||||
Gross Profit, 5 Yr. CAGR % | -9.03 | -2.32 | -1.51 | 1.52 | 1.83 | |||||
EBITDA, 5 Yr. CAGR % | -10.31 | 2.14 | -1.86 | 9.1 | 1.7 | |||||
EBITA, 5 Yr. CAGR % | -8.78 | 2.89 | -0.12 | 11.16 | 1.93 | |||||
EBIT, 5 Yr. CAGR % | -8.33 | 3.23 | -2.36 | 11.54 | 1.83 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -8.55 | 6.88 | -5.36 | 1.41 | 1.3 | |||||
Net Income, 5 Yr. CAGR % | -8.44 | -3.09 | -15.81 | -41.9 | 0.11 | |||||
Normalized Net Income, 5 Yr. CAGR % | -7.87 | 6.34 | -2.89 | 10.31 | 0.51 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -5.42 | 13.19 | 1.04 | 8.27 | 5.48 | |||||
Accounts Receivable, 5 Yr. CAGR % | -5.03 | -2.69 | 4.54 | 3.48 | 3.42 | |||||
Inventory, 5 Yr. CAGR % | -5.08 | 1.5 | 10.99 | 7.68 | 8.61 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -13.44 | -12.87 | 4.28 | 5.61 | 3.3 | |||||
Total Assets, 5 Yr. CAGR % | -3.76 | -3.04 | -1.84 | -4.97 | 1.88 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.2 | -4.11 | -36.13 | -50.82 | -28.06 | |||||
Common Equity, 5 Yr. CAGR % | -2.39 | -3.71 | -5.88 | -18.25 | -6.35 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.49 | -14.09 | -23.49 | 16.9 | 96.16 | |||||
Capital Expenditures, 5 Yr. CAGR % | -16.9 | -14.6 | 3.15 | 9.22 | 7.41 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -1.42 | 15.03 | -50.27 | -17.95 | -15.29 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -2.1 | 4.24 | -40.57 | -16.31 | -8.66 | |||||
Dividend Per Share, 5 Yr. CAGR % | 2.26 | 1.3 | -6.78 | 1.41 | 0.83 |
- Stock Market
- Equities
- AKZA Stock
- Financials Akzo Nobel N.V.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions